{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:52:07Z","timestamp":1789386727748,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Mega Project of Science Research for Major New Drugs Innovation and Development Research","award":["2014ZX09304316-003"],"award-info":[{"award-number":["2014ZX09304316-003"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.06.040","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T08:14:07Z","timestamp":1529914447000},"page":"4650-4656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus"],"prefix":"10.1016","volume":"36","author":[{"given":"Xinyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.06.040_b0005","doi-asserted-by":"crossref","unstructured":"Yu YX. Development of Japanese Encephalitis Attenuated Live Vaccine Virus SA14-14-2 and its Charcteristics. In: Tkachev S, editor. Encephalitis. Open Access: InTech, 2013, pp. 181\u2013206.","DOI":"10.5772\/52980"},{"key":"10.1016\/j.vaccine.2018.06.040_b0010","series-title":"Vaccines","first-page":"511","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2018"},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.040_b0015","first-page":"69","article-title":"Japanese Encephalitis vaccines: WHO position paper, February 2015 - recommendations","volume":"90","author":"Anon","year":"2015","journal-title":"Releve Epidemiologique Hebdomadaire"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.040_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00571925","article-title":"Identification of mutations that occurred on the genome of japanese encephalitis virus during the attenuation process","volume":"5","author":"Aihara","year":"1991","journal-title":"Virus Genes"},{"issue":"21","key":"10.1016\/j.vaccine.2018.06.040_b0025","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2018.06.040_b0030","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1099\/jgv.0.000574","article-title":"Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo","volume":"97","author":"Yun","year":"2016","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.040_b0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1099\/0022-1317-76-2-409","article-title":"Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain sa14","volume":"76","author":"Ni","year":"1995","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.040_b0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0042-6822(90)90519-W","article-title":"Nucleotide sequence of the virulent sa-14 strain of japanese encephalitis virus and its attenuated vaccine derivative, sa-14-14-2","volume":"177","author":"Nitayaphan","year":"1990","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.vaccine.2018.06.040_b0045","first-page":"833","article-title":"Biological and genetic stability of attenuated Japanese encephalitis vaccine virus strain SA14-14-2","volume":"21","author":"Xu","year":"2008","journal-title":"Chin J Biol"},{"issue":"23","key":"10.1016\/j.vaccine.2018.06.040_b0050","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1016\/j.vaccine.2014.03.074","article-title":"Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2","volume":"32","author":"Yang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.040_b0055","first-page":"51","article-title":"The molecular basis of neurovirulence attenuation for a Japanese encephalitis vaccine virus strain, SA14-14-2","volume":"1","author":"Li","year":"2011","journal-title":"Chin J Viral Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.040_b0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.virusres.2013.09.002","article-title":"Molecular phylogenetic and positive selection analysis of japanese encephalitis virus strains isolated from pigs in china","volume":"178","author":"Liu","year":"2013","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2018.06.040_b0065","first-page":"344","article-title":"Research on Culex tritaeniorhynchus and Culex pipiens quinquefascitatus intrathoracically infected with attenuated Japanese encephalitis virus SA14-14-2 vaccine strain","volume":"19","author":"Zhang","year":"2005","journal-title":"Chin J Exp Clin Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.040_b0070","first-page":"419","article-title":"Biological and molecular characteristics of live attenuated Japanese encephalitis vaccine virus strain SA14-14-2 inoculated intrathoracically to Culex tritaeniorhynchus","volume":"20","author":"Liu","year":"2007","journal-title":"Chin J Biol"},{"issue":"38","key":"10.1016\/j.vaccine.2018.06.040_b0075","first-page":"108","article-title":"Heterogeneity analysis of viral population of live attenuated Japanese encephalitis vaccine(SA14-14-2 strain)","volume":"6","author":"Yang","year":"2015","journal-title":"Int J Biologicals"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.040_b0080","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0264-410X(88)90103-X","article-title":"Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use","volume":"6","author":"Eckels","year":"1988","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.06.040_b0085","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12275-012-2336-6","article-title":"Biological and genetic properties of sa 14\u201314-2, a live-attenuated japanese encephalitis vaccine that is currently available for humans","volume":"50","author":"Song","year":"2012","journal-title":"J Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.040_b0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1988.39.214","article-title":"Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children","volume":"39","author":"Yu","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.06.040_b0095","first-page":"188","article-title":"Observation of safety and serological efficacy from large-scale field trial on Japanese encephalitis live vaccine","volume":"6","author":"Ma","year":"1993","journal-title":"Chin J Biol"},{"key":"10.1016\/j.vaccine.2018.06.040_b0100","first-page":"60","article-title":"Observation on the side reaction after vaccination with Japanese encephalitis live vaccine","volume":"14","author":"Huang","year":"1998","journal-title":"Chin J Zoonoses"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.040_b0105","first-page":"38","article-title":"A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas","volume":"20","author":"Zhou","year":"1999","journal-title":"Chin J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.06.040_b0110","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/517323","article-title":"Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects","volume":"176","author":"Liu","year":"1997","journal-title":"J Infec Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2018.06.040_b0115","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.vaccine.2013.11.107","article-title":"Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005\u20132012","volume":"32","author":"Liu","year":"2014","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2018.06.040_b0120","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1016\/j.vaccine.2017.05.021","article-title":"Post-marketing safety surveillance for inactivated and live-attenuated japanese encephalitis vaccines in china, 2008\u20132013","volume":"35","author":"Wu","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.040_b0125","unstructured":"Glovax. Summary of Live attenuated SA14-14-2 Japanese Encephalitis vaccine post-marketing surveillance study in Korea (2002-2008). Seoul: Glovax Clinical Research and Regulation Regulatory Affairs; 2008."},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.040_b0130","first-page":"10","article-title":"Adverse events following immunisation with SA 14\u201314-2 Japanese encephalitis vaccine in children of Kolar in Karnataka","volume":"110","author":"Ranganath","year":"2012","journal-title":"J Ind Med Assoc"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.040_b0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4038\/cmj.v61i3.8344","article-title":"Safety of live attenuated Japanese encephalitis vaccine given at the age of 9 months in National Immunisation Programme of Sri Lanka","volume":"61","author":"Sanchayan","year":"2016","journal-title":"Ceylon Med J"},{"issue":"34","key":"10.1016\/j.vaccine.2018.06.040_b0140","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1080\/21645515.2017.1356496","article-title":"Use of the live attenuated Japanese encephalitis vaccine SA 14\u201314-2 in children: a review of safety and tolerability studies","volume":"13","author":"Ginsburg","year":"2017","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.vaccine.2018.06.040_b0145","first-page":"1","article-title":"The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism","author":"Liu","year":"2018","journal-title":"Protein & Cell"},{"issue":"27","key":"10.1016\/j.vaccine.2018.06.040_b0150","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","article-title":"Single dose of SA 14\u201314-2 vaccine provides long-term protection against Japanese encephalitis: a case\u2013control study in Nepalese children 5 years after immunization","volume":"25","author":"Tandan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.040_b0155","first-page":"38","article-title":"A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas","volume":"20","author":"Zhou","year":"1999","journal-title":"Chin J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.040_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005866","article-title":"Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal","volume":"11","author":"Upreti","year":"2017","journal-title":"Plos Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2018.06.040_b0165","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1586\/14787210.2014.929498","article-title":"Control of Japanese encephalitis in Asia: the time is now","volume":"12","author":"Hills","year":"2014","journal-title":"Expert Rev Anti-infe"},{"issue":"46","key":"10.1016\/j.vaccine.2018.06.040_b0170","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1016\/j.vaccine.2014.09.012","article-title":"Lot-to-lot consistency of live attenuated sa 14\u201314-2 japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product","volume":"32","author":"Zaman","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:48Z","timestamp":1759400868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18308685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":34,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X18308685"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}